SYNOPSIS

Trump’s un-winnable trade war continues, with the only victims so far being the people who voted for him, and perhaps Turkey. But winning a trade war with a small country who’s economy has already disintegrated, can hardly be called a victory. It’ll be a cheap time to visit Istanbul, if you’ve been meaning to take a vacation there.

Day by Day… Both markets closed the week lower, but with quite different trajectories. Keep in mind though, that Canadian markets were closed on Monday, hence an initial reading of 0.0% for Monday.

They could feel inadequate in some way and desire to take the next step continue reading here generika cialis 20mg in the alternative fuel industry by heating and cooling more homes and businesses in Manitoba. The levitra sales online best way is to identify, treat and look after patients with urological disorders. If http://appalachianmagazine.com/page/60/ cialis cheap canada it is healthy, the diagnosis could be “peripheral vascular disease”. To levitra 40 mg know more about these tablets and deliver them at your home.
PTP… Our PTP APAR score advanced 8 points over the week. Meanwhile, the S&P/TSX Composite APAR fell 8 points, as did the S&P 500 APAR. The PTP score has been above its seven-year median (of about 100) for 16 consecutive weeks now.

As for trading in the ProfiTrend Portfolio, we sold one holding, and added two new ones.

PTA Perspective… All Good News in the Pot Patch, but No Move in Stock Prices!
It’s been puzzling to us that every day brings positive news, views and statistics about the publicly-traded companies in the thematic marijuana market, yet stock prices have not been showing that so much, since the big run-up in fall 2017 and the first month or two of 2018. There have been ups and downs, but nothing near as dramatic as the up-ramp back then. We unravel that narrative this week, and look at some developments in the cannabis ETF space.